AGL
Agilon Health, Inc.
NYSE · Healthcare · Medical - Care Facilities · US
$88.50
+2.34%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 5.9B | 5.9B | 6.1B | 4.3B | 2.4B |
| Cost of Revenue | 5.9B | 6.1B | 6.1B | 4.2B | 2.3B |
| Gross Profit | 82.0K | (188.6M) | 4.8M | 69.7M | 111.4M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 259.0M | 238.5M | 268.9M | 285.8M | 207.8M |
| General & Admin Expense | 259.0M | 238.5M | 268.9M | 285.8M | 207.8M |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | 6.2M | (6.1M) | 28.1M | 16.0M | 8.9M |
| Total Operating Expenses | 265.2M | 232.5M | 297.0M | 301.8M | 216.7M |
| Cost and Expenses | 6.2B | 6.4B | 6.4B | 4.5B | 2.5B |
| Operating Income (EBIT) | (265.1M) | (421.1M) | (292.1M) | (232.1M) | (105.4M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 3.4M | 6.6M | 6.2M | 6.7M | 4.5M |
| Net Interest Income | (3.4M) | (6.6M) | (6.2M) | (6.7M) | (4.5M) |
| Other Non-Op Income/Expense | 14.6M | 17.0M | 43.3M | 37.7M | 14.7M |
| Non-Operating Income (excl Interest) | (3.1M) | (23.6M) | (49.5M) | (44.3M) | (19.2M) |
| EBT (Pre-Tax Income) | (250.6M) | (404.1M) | (248.8M) | (194.5M) | (90.7M) |
| Income Tax Expense | 590.0K | 1.3M | 1.5M | 791.0K | 1.6M |
| Bottom Line | |||||
| Net Income | (251.2M) | (405.3M) | (260.2M) | (262.6M) | (106.6M) |
| Earnings from Cont. Ops | (251.2M) | (405.3M) | (250.3M) | (195.3M) | (92.3M) |
| Earnings from Discont. Ops | — | — | (9.8M) | (67.5M) | (14.6M) |
| Bottom Line Net Income | (251.2M) | (405.3M) | (260.2M) | (262.6M) | (106.6M) |
| Per Share | |||||
| Basic EPS | ($15.38) | ($24.50) | ($15.75) | ($16.00) | ($6.50) |
| Diluted EPS | ($15.41) | ($24.50) | ($15.75) | ($16.00) | ($6.50) |
| Revenue Per Share | $354.39 | $358.27 | $368.68 | $263.89 | $146.28 |
| Shares | |||||
| Basic Shares Outstanding | 16.7M | 16.6M | 16.4M | 16.4M | 16.3M |
| Diluted Shares Outstanding | 17.2M | 16.6M | 16.4M | 16.4M | 16.3M |
| Profitability Metrics | |||||
| EBITDA | (234.0M) | (368.9M) | (218.2M) | (167.6M) | (72.4M) |
| D&A | 28.1M | 28.6M | 24.5M | 20.2M | 13.8M |
| EBIT | (262.1M) | (397.5M) | (242.6M) | (187.8M) | (86.2M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026